cl 387785 has been researched along with Adenomatous Polyposis Coli in 1 studies
CL 387785: structure in first source
N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide : A member of the class of quinazolines that is 4,6-diaminoquinazoine in which the one of the hydrogens attached to the amino group at position 4 has been replaced by a m-bromophenyl group while one of the hydrogens attached to the amino group at position 6 has been replaced by a but-2-ynoyl group.
Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Torrance, CJ | 1 |
| Jackson, PE | 1 |
| Montgomery, E | 1 |
| Kinzler, KW | 1 |
| Vogelstein, B | 1 |
| Wissner, A | 1 |
| Nunes, M | 1 |
| Frost, P | 1 |
| Discafani, CM | 1 |
1 other study available for cl 387785 and Adenomatous Polyposis Coli
| Article | Year |
|---|---|
Combinatorial chemoprevention of intestinal neoplasia.
Topics: Adenomatous Polyposis Coli; Aminoquinolines; Aniline Compounds; Animals; Anti-Inflammatory Agents, N | 2000 |